Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Wellnex Life Ltd ( (AU:WNX) ).
Wellnex Life Ltd has confirmed the cessation of 146,316 listed options (WNXAB), which expired on 6 February 2026 with an exercise price of $7.50 and lapsed without being exercised or converted. The expiration slightly reduces the company’s potential future share dilution from this series of options, clarifying its issued capital structure for investors and simplifying its securities on issue.
The notification, lodged as an Appendix 3H with the ASX, formally records the removal of these options from Wellnex Life’s capital base and updates the market on the change. While there is no immediate cash inflow from the unexercised options, the move provides greater transparency for stakeholders assessing the company’s equity position and potential overhang from derivative securities.
The most recent analyst rating on (AU:WNX) stock is a Sell with a A$0.10 price target. To see the full list of analyst forecasts on Wellnex Life Ltd stock, see the AU:WNX Stock Forecast page.
More about Wellnex Life Ltd
Wellnex Life Ltd, listed on the ASX under the code WNX, operates in the health and wellness sector, focusing on developing and marketing consumer health products. The company targets Australian and potentially broader regional markets with a portfolio that typically includes over-the-counter and wellness-focused offerings aimed at retail and pharmacy channels.
YTD Price Performance: 11.70%
Average Trading Volume: 88,698
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$7.35M
See more insights into WNX stock on TipRanks’ Stock Analysis page.